e-learning
resources
Stockholm 2007
Monday 17.09.2007
COPD, sarcoidosis, idiopathic pulmonary fibrosis, cystic fibrosis, gastro-oesophageal reflux and cough variant asthma - pathogenesis and differential diagnosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Analysis of pathogenic secretory immunity factors in saliva from patients with chronic obstructive pulmonary disease
E. Altynbaeva, S. N. Teplova, G. L. Ignatova, A. R. Altynbaev, O. V. Danilova (Ozyorsk, Chelyabinsk Region, Chelyabinsk, Russian Federation)
Source:
Annual Congress 2007 - COPD, sarcoidosis, idiopathic pulmonary fibrosis, cystic fibrosis, gastro-oesophageal reflux and cough variant asthma - pathogenesis and differential diagnosis
Session:
COPD, sarcoidosis, idiopathic pulmonary fibrosis, cystic fibrosis, gastro-oesophageal reflux and cough variant asthma - pathogenesis and differential diagnosis
Session type:
Thematic Poster Session
Number:
2227
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Altynbaeva, S. N. Teplova, G. L. Ignatova, A. R. Altynbaev, O. V. Danilova (Ozyorsk, Chelyabinsk Region, Chelyabinsk, Russian Federation). Analysis of pathogenic secretory immunity factors in saliva from patients with chronic obstructive pulmonary disease. Eur Respir J 2007; 30: Suppl. 51, 2227
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
Mechanisms of impaired anti-bacterial Th1 responses in patients with chronic obstructive pulmonary disease
Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Year: 2018
Localization of respiratory viral antigens in patients with exacerbations of non allergic late-onset asthma and chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 411s
Year: 2004
Presence of mimivirus in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
Exacerbations of chronic obstructive pulmonary disease: when are bacteria important?
Source: Eur Respir J 2002; 20: 9S-19S
Year: 2002
The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018
Analysis of parameters of lung function in patients with severe chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 214s
Year: 2001
Epigenetic-like regulation of signalling proteins in chronic obstructive pulmonary disease
Source: International Congress 2019 – Effects of environmental exposures in lung pathology and the underlying mechanisms
Year: 2019
Multiple inflammatory hits and the pathogenesis of severe airway disease
Source: Eur Respir J 2006; 27: 884-888
Year: 2006
Growth factors in chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 320s
Year: 2004
Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease
Source: Eur Respir J , 49 (3) 1601328; DOI: 10.1183/13993003.01328-2016
Year: 2017
Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: 325-331
Year: 2002
Investigating the fatigue and related factors in patients with chronic obstructive pulmonary disease.
Source: International Congress 2017 – Assessing functional outcomes in chronic respiratory disease
Year: 2017
Bacterial infections in patients with acute exacerbation of chronic obstructive pulmonary diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 544s
Year: 2002
Respiratory viral infections in Iranian patients with exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Year: 2010
Stable chronic obstructive pulmonary disease-bronchial colonization and inflammatory response
Source: Eur Respir J 2001; 18: Suppl. 33, 105s
Year: 2001
Dynamics etiologic spectrum of infectious exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
Mucus production in chronic obstructive lung diseases: relationship with infections
Source: Annual Congress 2006 - Infections and chronic obstructive lung diseases
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept